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Sir 
Patients with rheumatoid arthritis (RA) are at increased risk of comorbidities 
particularly cardiovascular disease and osteoporosis [1, 2]. NICE standards of care 
for rheumatoid arthritis (RA) recommend patients should receive a holistic annual 
review that should include an assessment of disease activity and severity, active 
screening for and management of comorbidities [3] and assessment of the impact of 
RA on quality of life. In 2013, RA was included in the Quality Outcomes Framework 
(QOF) of the UK general practice contract. General Practitioners (GPs) were 
incentivised to provide a face to face annual review for RA patients, including 
cardiovascular and fracture risk screening, mirroring the routine care for patients with 
other long term conditions such as diabetes – a model which improves quality of 
care and clinically important outcomes [4]. The aim of this study was to investigate 
what domains GPs report including in their annual review for patients with RA and to 
determine the role of the multidisciplinary team in providing these reviews.  
We conducted a national cross sectional survey in 2013 to investigate the primary 
care management of RA. 5000 randomly selected GPs were asked to complete a 
brief questionnaire investigating their management strategies for patients with RA. 
Participants were presented with a predefined list of 12 measures that could be 
included in an annual review (presented in Table 1: including cardiovascular disease, 
osteoporosis and depression screening) and asked to indicate which measures they 
routinely included. Furthermore, GPs were asked which screening tools they used 
for cardiovascular disease and osteoporosis screening and which members of the 
multidisciplinary team conducted these reviews.  
1388 (27.8%) completed questionnaires were returned. The majority (1052, 75.6%) 
of responders were GP partners, with a mean (SD) age of 47 (9.4) years.  705 
participants (50.8%) were female. The majority of responding GPs (1083, 80.4%) felt 
that a primary care annual review was of benefit to their RA patients, although only 
712 (51.2%) GPs felt that RA should be included in the QOF component of the GP 
contract. 939 (67.7%) GPs indicated they were aware of the NICE Standards of Care 
for RA, although only half (693, 49.9%) felt they impacted on their clinical practice. 
Only 767 (55.3%) GPs thought their patients had access to an annual review in 
secondary care. 
The individual measures that GPs reported including in their annual review are 
detailed in Table 1. The most frequently incorporated components were medication 
review (1232, 88.8%), followed by cardiovascular risk assessment (1139, 82.1%). 
The latter was most commonly performed by practice nurses using QRISK (1214 
(87.5%). Osteoporosis risk assessment was also commonly performed (1118, 
80.5%), usually by GPs themselves (1023, 73.7%), with a minority of GPs thought 
osteoporosis screening for their patients was performed in secondary care (192, 
13.8%). Assessments of RA disease activity (556, 40.1%) or disease complications 
(329, 23.7%) and routine use of DAS28 was uncommon (27, 1.9%).  
This large general practice survey suggests that despite NICE advocating a holistic 
annual review for patients with RA, at present primary care reviews focus on key 
QOF domains such as cardiovascular disease and osteoporosis screening. Further 
studies will be required to determine whether screening still occurs now that RA is no 
longer incentivised in the QOF. Importantly, key comorbidities associated with a poor 
outcome, such as depression, are not routinely screened for, meaning opportunities 
for intervention are missed. The disease specific components of annual review such 
as disease activity and assessment of complications still largely occur in secondary 
care.  
Good communication systems are needed across the healthcare setting to prevent 
duplication of screening and fragmentation of care for these patients, to ensure that 
annual review is truly holistic and to ensure that common comorbidities such as 
depression are not neglected in this patient group.  
 
Table 1: Measures included in a primary care annual review.  
 
Measure N (%) 
Medication review 1232 (88.8) 
Cardiovascular disease risk assessment  1139 (82.1) 
BP measurement 1139 (82.1) 
Osteoporosis risk assessment 1118 (79.3) 
Pain levels/analgesia review 1052 (75.6) 
DMARD monitoring 956 (68.8) 
Depression screening 859 (61.8) 
Mobility assessment 808 (58.2) 
RA flare frequency 569 (41.0) 
Measurement of RA disease activity 556 (40.1) 
Screening for RA complications 329 (23.7) 
DAS28 measurement 27 (1.9) 
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